CLINICAL TRIALS PROFILE FOR ETHOSUXIMIDE
✉ Email this page to a colleague
All Clinical Trials for ethosuximide
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00088452 ↗ | Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 3 | 2004-07-01 | The purpose of this study is to determine the best initial treatment for childhood absence epilepsy. |
| NCT00088452 ↗ | Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study | Completed | Children's Hospital Medical Center, Cincinnati | Phase 3 | 2004-07-01 | The purpose of this study is to determine the best initial treatment for childhood absence epilepsy. |
| NCT00689585 ↗ | Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) | Terminated | McGill University | Phase 2 | 2008-09-01 | Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS. |
| NCT00689585 ↗ | Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) | Terminated | McGill University Health Center | Phase 2 | 2008-09-01 | Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS. |
| NCT00689585 ↗ | Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) | Terminated | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 | 2008-09-01 | Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS. |
| NCT01122381 ↗ | Comparison of a Drug and Placebo in the Prevention of Migraine Headaches | Terminated | Thomas Jefferson University | Phase 1/Phase 2 | 2011-12-01 | The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans. |
| NCT01122381 ↗ | Comparison of a Drug and Placebo in the Prevention of Migraine Headaches | Terminated | University of Pittsburgh | Phase 1/Phase 2 | 2011-12-01 | The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ethosuximide
Condition Name
Clinical Trial Locations for ethosuximide
Trials by Country
Clinical Trial Progress for ethosuximide
Clinical Trial Phase
Clinical Trial Sponsors for ethosuximide
Sponsor Name
